T 1902/11 (Human IL-23/MERCK SHARP & DOHME) of 11.12.2014
- European Case Law Identifier
- ECLI:EP:BA:2014:T190211.20141211
- Date of decision
- 11 December 2014
- Case number
- T 1902/11
- Online on
- 18 February 2015
- Petition for review of
- -
- Application number
- 00961688.9
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- MAMMALIAN INTERLEUKIN-12 P40 AND INTERLEUKIN B30. COMBINATIONS THEREOF. ANTIBODIES. USES IN PHARMACEUTICAL COMPOSITIONS
- Applicant name
- Merck Sharp & Dohme Corp.
- Opponent name
- Janssen Biotech, Inc.
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83European Patent Convention Art 84European Patent Convention Art 123(2)
- Keywords
- Main request - requirements of the EPC met (yes)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent based on claims 1 to 3 of the Main Request filed at the oral proceedings, and a description to be adapted thereto.